Janney Montgomery Scott
ADMA icon

Janney Montgomery Scott’s ADMA Biologics ADMA Stock Holding History

Janney Montgomery Scott’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$695K Buy
77,118
+7,744
+11% +$122K ﹤0.01% 1855
2025
Q4 		$1.26M Buy
69,374
+2,579
+4% +$43.5K ﹤0.01% 1598
2025
Q3 		$979K Buy
66,795
+15,448
+30% +$265K ﹤0.01% 1705
2025
Q2 		$935K Sell
51,347
-19,644
-28% -$401K ﹤0.01% 1616
2025
Q1 		$1.41M Buy
70,991
+4,865
+7% +$84.1K ﹤0.01% 1335
2024
Q4 		$1.13M Sell
66,126
-6,603
-9% -$124K ﹤0.01% 1473
2024
Q3 		$1.45M Buy
+72,729
New +$1.13M ﹤0.01% 1304

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Janney Montgomery Scott's ADMA Position: Q1 2026 in Review

Janney Montgomery Scott increased its ADMA Biologics (ADMA) stake by 11% in Q1 2026, buying an estimated $122K and bringing the position to 77,118 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Janney Montgomery Scott first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Janney Montgomery Scott held 77,118 shares of ADMA Biologics worth $695K as of Q1 2026.
  • Janney Montgomery Scott bought 7,744 ADMA Biologics shares in Q1 2026, an estimated $122K.
  • ADMA Biologics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1855 holding.
  • Janney Montgomery Scott first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • Janney Montgomery Scott's ADMA Biologics position peaked at $1.45M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.